A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

580

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Major Depression
Interventions
DRUG

SSR125543

"Pharmaceutical form: capsule~Route of administration: oral"

DRUG

escitalopram

"Pharmaceutical form: encapsulated tablets~Route of administration: oral"

DRUG

placebo

"Pharmaceutical form: capsule~Route of administration: oral"

Trial Locations (73)

1180

Sanofi-Aventis Investigational Site Number 056003, Brussels

1730

Sanofi-Aventis Investigational Site Number 056002, Asse

3629

Sanofi-Aventis Investigational Site Number 710002, Durban

4000

Sanofi-Aventis Investigational Site Number 056001, Liège

7130

Sanofi-Aventis Investigational Site Number 710004, Somerset West

7530

Sanofi-Aventis Investigational Site Number 710005, Cape Town

7646

Sanofi-Aventis Investigational Site Number 710001, Cape Town

10613

Sanofi-Aventis Investigational Site Number 233001, Tallinn

10629

Sanofi-Aventis Investigational Site Number 276002, Berlin

11911

Sanofi-Aventis Investigational Site Number 233002, Tallinn

13419

Sanofi-Aventis Investigational Site Number 233004, Tallinn

19053

Sanofi-Aventis Investigational Site Number 276001, Schwerin

20100

Sanofi-Aventis Investigational Site Number 246004, Turku

28832

Sanofi-Aventis Investigational Site Number 276008, Achim

30029

Sanofi-Aventis Investigational Site Number 250005, Nîmes

31000

Sanofi-Aventis Investigational Site Number 250002, Toulouse

33120

Sanofi-Aventis Investigational Site Number 250008, Arcachon

33200

Sanofi-Aventis Investigational Site Number 246002, Tampere

34295

Sanofi-Aventis Investigational Site Number 250003, Montpellier

38043

Sanofi-Aventis Investigational Site Number 250001, Grenoble

39100

Sanofi-Aventis Investigational Site Number 250007, Dole

44700

Sanofi-Aventis Investigational Site Number 250004, Orvault

50406

Sanofi-Aventis Investigational Site Number 233003, Tartu

68159

Sanofi-Aventis Investigational Site Number 276006, Mannheim

78990

Sanofi-Aventis Investigational Site Number 250006, Élancourt

80333

Sanofi-Aventis Investigational Site Number 276007, München

81107

Sanofi-Aventis Investigational Site Number 703102, Bratislava

82606

Sanofi-Aventis Investigational Site Number 703101, Bratislava

97070

Sanofi-Aventis Investigational Site Number 276003, Würzburg

117152

Sanofi-Aventis Investigational Site Number 643006, Moscow

190005

Sanofi-Aventis Investigational Site Number 643001, Saint Petersburg

190121

Sanofi-Aventis Investigational Site Number 643009, Saint Petersburg

Sanofi-Aventis Investigational Site Number 643010, Saint Petersburg

191119

Sanofi-Aventis Investigational Site Number 643011, Saint Petersburg

192019

Sanofi-Aventis Investigational Site Number 643003, Saint Petersburg

194044

Sanofi-Aventis Investigational Site Number 643002, Saint Petersburg

214019

Sanofi-Aventis Investigational Site Number 643007, Smolensk

344010

Sanofi-Aventis Investigational Site Number 643008, Rostov-on-Don

443016

Sanofi-Aventis Investigational Site Number 643004, Samara

603155

Sanofi-Aventis Investigational Site Number 643005, Nizhny Novgorod

8053095

Sanofi-Aventis Investigational Site Number 152005, Santiago

L7R 4E2

Sanofi-Aventis Investigational Site Number 124011, Burlington

N7M 1B7

Sanofi-Aventis Investigational Site Number 124012, Chatham

T6L 5X8

Sanofi-Aventis Investigational Site Number 124004, Edmonton

J9A 1K7

Sanofi-Aventis Investigational Site Number 124003, Gatineau

V1Y 1Z9

Sanofi-Aventis Investigational Site Number 124001, Kelowna

L5M 4N4

Sanofi-Aventis Investigational Site Number 124006, Mississauga

V2A 4M4

Sanofi-Aventis Investigational Site Number 124008, Penticton

J1V 4J7

Sanofi-Aventis Investigational Site Number 124007, Sherbrooke

M3H 5S4

Sanofi-Aventis Investigational Site Number 124009, Toronto

750-0710

Sanofi-Aventis Investigational Site Number 152001, Santiago

751-0041

Sanofi-Aventis Investigational Site Number 152002, Santiago

756-0356

Sanofi-Aventis Investigational Site Number 152003, Santiago

890-0085

Sanofi-Aventis Investigational Site Number 152006, Santiago

Unknown

Sanofi-Aventis Investigational Site Number 152004, Santiago

Sanofi-Aventis Investigational Site Number 152008, Viña del Mar

236-0002

Sanofi-Aventis Investigational Site Number 152007, Valparaíso

00260

Sanofi-Aventis Investigational Site Number 246001, Helsinki

00530

Sanofi-Aventis Investigational Site Number 246003, Helsinki

04400

Sanofi-Aventis Investigational Site Number 246005, Järvenpää

01307

Sanofi-Aventis Investigational Site Number 276004, Dresden

04107

Sanofi-Aventis Investigational Site Number 276005, Leipzig

2512 VA

Sanofi-Aventis Investigational Site Number 528001, The Hague

07101

Sanofi-Aventis Investigational Site Number 703104, Michalovce

979 12

Sanofi-Aventis Investigational Site Number 703105, Rimavská Sobota

04801

Sanofi-Aventis Investigational Site Number 703103, Rožňava

0157

Sanofi-Aventis Investigational Site Number 710006, Centurion

0181

Sanofi-Aventis Investigational Site Number 710003, Pretoria

582 16

Sanofi-Aventis Investigational Site Number 752004, Linköping

223 61

Sanofi-Aventis Investigational Site Number 752002, Lund

211 52

Sanofi-Aventis Investigational Site Number 752003, Malmo

112 34

Sanofi-Aventis Investigational Site Number 752005, Stockholm

753 10

Sanofi-Aventis Investigational Site Number 752001, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT01034995 - A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter